Clinical trial
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer…
NCT00335959 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00335959 |
|---|---|
| Title | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery |
| Official title | Neoadjuvant Chemoradiation Therapy With Oxaliplatin and Capecitabine for Patients With Surgically Resectable Gastric Cancer: A Pilot Phase II Trial With Molecular Correlates |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, oxaliplatin, conventional surgery, radiation therapy |
| Enrollment | 7 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2009 |
| First posted | Jun 12, 2006 |
| Last update posted | Aug 17, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: